28 related articles for article (PubMed ID: 15910404)
1. Statins and Peripheral Arterial Disease: A Narrative Review.
Jansen-Chaparro S; López-Carmona MD; Cobos-Palacios L; Sanz-Cánovas J; Bernal-López MR; Gómez-Huelgas R
Front Cardiovasc Med; 2021; 8():777016. PubMed ID: 34881314
[TBL] [Abstract][Full Text] [Related]
2. Hypercholesterolemia and microvascular dysfunction: interventional strategies.
Stapleton PA; Goodwill AG; James ME; Brock RW; Frisbee JC
J Inflamm (Lond); 2010 Nov; 7():54. PubMed ID: 21087503
[TBL] [Abstract][Full Text] [Related]
3. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Stender S; Schuster H; Barter P; Watkins C; Kallend D;
Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
[TBL] [Abstract][Full Text] [Related]
4. Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients.
Huang CY; Wu TC; Lin WT; Leu HB; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2006 Feb; 36(2):76-84. PubMed ID: 16436088
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant effect of simvastatin is not enhanced by its association with alpha-tocopherol in hypercholesterolemic patients.
Pereira EC; Bertolami MC; Faludi AA; Sevanian A; Abdalla DS
Free Radic Biol Med; 2004 Nov; 37(9):1440-8. PubMed ID: 15454283
[TBL] [Abstract][Full Text] [Related]
6. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
[TBL] [Abstract][Full Text] [Related]
7. Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease.
Gryglewski RJ; Grodzińska L; Kostka-Trabka E; Korbut R; Bieroón K; Goszcz A; Sławiński M
Wien Klin Wochenschr; 1996; 108(4):111-6. PubMed ID: 8867484
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin effects in normo- and hypercholesterolaemic patients with peripheral arterial occlusive disease: a pilot study.
Grodzińska L; Starzyk D; Bieroń K; Goszcz A; Korbut R
Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):413-9. PubMed ID: 15910404
[TBL] [Abstract][Full Text] [Related]
9. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
[TBL] [Abstract][Full Text] [Related]
10. [Role of lipid lowering therapy in patients with peripheral arterial occlusive disease].
Wittlinger T; Kröger K
Herz; 2004 Feb; 29(1):12-6. PubMed ID: 14968337
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic actions of statins.
Szczeklik A; Undas A; Musial J; Gajewski P; Swadzba J; Jankowski M
Med Sci Monit; 2001; 7(6):1381-5. PubMed ID: 11687759
[TBL] [Abstract][Full Text] [Related]
12. [The other face of statins].
Kaletha K; Chodorowski Z; Sein Anand J; Szydłowska M; Rybakowska I; Nagel-Starczynowska G
Przegl Lek; 2002; 59(4-5):364-6. PubMed ID: 12184008
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
